Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High frequency of copy number alterations in myeloid leukaemia of Down syndrome.
Blink M, van den Heuvel-Eibrink MM, Aalbers AM, Balgobind BV, Hollink IH, Meijerink JP, van der Velden VH, Beverloo BH, de Haas V, Hasle H, Reinhardt D, Klusmann JH, Pieters R, Calado RT, Zwaan CM. Blink M, et al. Among authors: klusmann jh. Br J Haematol. 2012 Sep;158(6):800-3. doi: 10.1111/j.1365-2141.2012.09224.x. Epub 2012 Jul 7. Br J Haematol. 2012. PMID: 22775985 Free article. No abstract available.
Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias.
Issa H, Bhayadia R, Winkler R, Swart LE, Heckl D, Klusmann JH. Issa H, et al. Among authors: klusmann jh. Leukemia. 2023 Jul;37(7):1583-1587. doi: 10.1038/s41375-023-01937-6. Epub 2023 Jun 13. Leukemia. 2023. PMID: 37311946 Free PMC article. No abstract available.
Double trouble: IRAK1/4 inhibitors in AML/MDS.
Uckelmann HJ, Klusmann JH. Uckelmann HJ, et al. Among authors: klusmann jh. Blood. 2023 Sep 14;142(11):945-946. doi: 10.1182/blood.2023020812. Blood. 2023. PMID: 37707874 No abstract available.
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
Ehlers S, Herbst C, Zimmermann M, Scharn N, Germeshausen M, von Neuhoff N, Zwaan CM, Reinhardt K, Hollink IH, Klusmann JH, Lehrnbecher T, Roettgers S, Stary J, Dworzak M, Welte K, Creutzig U, Reinhardt D. Ehlers S, et al. Among authors: klusmann jh. J Clin Oncol. 2010 May 20;28(15):2591-7. doi: 10.1200/JCO.2009.25.9010. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406937 Clinical Trial.
DNMT3A mutations are rare in childhood acute myeloid leukemia.
Thol F, Heuser M, Damm F, Klusmann JH, Reinhardt K, Reinhardt D. Thol F, et al. Among authors: klusmann jh. Haematologica. 2011 Aug;96(8):1238-40. doi: 10.3324/haematol.2011.046839. Epub 2011 Jun 17. Haematologica. 2011. PMID: 21685466 Free PMC article. No abstract available.
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
Alford KA, Reinhardt K, Garnett C, Norton A, Böhmer K, von Neuhoff C, Kolenova A, Marchi E, Klusmann JH, Roberts I, Hasle H, Reinhardt D, Vyas P; International Myeloid Leukemia-Down Syndrome Study Group. Alford KA, et al. Among authors: klusmann jh. Blood. 2011 Aug 25;118(8):2222-38. doi: 10.1182/blood-2011-03-342774. Epub 2011 Jun 29. Blood. 2011. PMID: 21715302 Free article.
91 results